The effect of a celebrity health disclosure on demand for health care: trends in BRCA testing and subsequent health services use

Journal of Community Genetics

Volumn 8, Issue 2, 2017, Pages 141-146

  Roberts, Megan C ^a,b   Dusetzina, Stacie B ^a,b,c  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNC Hamner Institute for Drug Safety Sciences   (United States)

Author keywords

Breast cancer; Costs; Genetic testing; Health services use

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HEALTH CARE NEED; HEALTH INSURANCE; HEALTH SERVICE; HUMAN; MAMMOGRAPHY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE; REGRESSION ANALYSIS; REIMBURSEMENT; TIME SERIES ANALYSIS; TREND STUDY; WOMEN'S HEALTH;

EID: 85015200674     PISSN: 1868310X     EISSN: 18686001     Source Type: Journal    
DOI: 10.1007/s12687-017-0295-7     Document Type: Article

References (25)

1. Andersen M (1995) Revisiting the behavioral model and access to medical care: does it matter?. Journal of health and social behavior: 1–10
2. Anderson K, Jacobson JS, Heitjan DF, Zivin JG, Hershman D, Neugut AI, Grann VR (2006) Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation. Ann Intern Med 144:397–406
3. Armstrong K, Micco E, Carney A, Stopfer J, Putt M (2005) Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA 293:1729–1736. doi:10.1001/jama.293.14.1729
4. Armstrong J et al. (2015) Utilization and outcomes of BRCA genetic testing and counseling in a national commercially insured population: the ABOUT study JAMA oncology:1–10 doi:10.1001/jamaoncol.2015.3048
5. Berliner JL, Fay AM, Cummings SA, Burnett B, Tillmanns T (2013) NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer. J Genet Couns 22(2):155–163
6. Borzekowski DL, Guan Y, Smith KC, Erby LH, Roter DL (2014) The Angelina effect: immediate reach, grasp, and impact of going public. Genetics in medicine: official journal of the American College of Medical Genetics 16:516–521. doi:10.1038/gim.2013.181
7. Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 25:1329–1333. doi:10.1200/JCO.2006.09.1066
8. Cram P, Fendrick AM, Inadomi J, Cowen ME, Carpenter D, Vijan S (2003) The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. Arch Intern Med 163:1601–1605. doi:10.1001/archinte.163.13.1601
9. Desai S, Jena AB (2016) Do celebrity endorsements matter? Observational study of BRCA gene testing and mastectomy rates after Angelina Jolie’s New York Times editorial BMJ 355: i6357 doi.org/10.1136/bmj.i6357
10. Evans DG et al. (2014) The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services Breast Cancer Res 16:442 doi:10.1186/s13058–014–0442-6
11. Finlay E et al (2008) Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Genet Test 12:81–91. doi:10.1089/gte.2007.0037
12. Guillem JG et al (2006) ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 24:4642–4660. doi:10.1200/JCO.2005.04.5260
13. Jacobsen GD, Jacobsen KH (2011) Health awareness campaigns and diagnosis rates: evidence from National Breast Cancer Awareness Month. J Health Econ 30:55–61. doi:10.1016/j.jhealeco.2010.11.005
14. Jagsi R et al (2015) Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 33:1584–1591. doi:10.1200/JCO.2014.58.5885
15. Jolie A (2013) My medical choice. The New York Times Company, New York
16. Juthe RH, Zaharchuk A, Wang C (2015) Celebrity disclosures and information seeking: the case of Angelina Jolie. Genetics in medicine: official journal of the American College of Medical Genetics 17:545–553. doi:10.1038/gim.2014.141
17. Kesselheim AS, Cook-Deegan RM, Winickoff DE, Mello MM (2013) Gene patenting—the supreme court finally speaks. N Engl J Med 369:869–875. doi:10.1056/NEJMhle1308199
18. King MC, Marks JH, Mandell JB, New York Breast Cancer Study Group (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643–646. doi:10.1126/science.1088759
19. Lacour RA et al (2008) What women with ovarian cancer think and know about genetic testing. Gynecol Oncol 111:132–136. doi:10.1016/j.ygyno.2008.06.016
20. Lebo PB, Quehenberger F, Kamolz LP, Lumenta DB (2015) The Angelina effect revisited: exploring a media-related impact on public awareness. Cancer 121:3959–3964. doi:10.1002/cncr.29461
21. Moyer VA, USPSTF (2014) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement Annals of internal medicine 160:271–281. doi:10.7326/M13-2747
22. Noar SM, Althouse BM, Ayers JW, Francis DB, Ribisl KM (2015) Cancer information seeking in the digital age: effects of Angelina Jolie’s prophylactic mastectomy announcement. Medical decision making: an international journal of the Society for Medical Decision Making 35:16–21. doi:10.1177/0272989X14556130
23. Thackeray R, Burton SH, Giraud-Carrier C, Rollins S, Draper CR (2013) Using Twitter for breast cancer prevention: an analysis of breast cancer awareness month Bmc Cancer 13 doi:Unsp 50810.1186/1471–2407–13-508
24. Truven Health Analytics (2015) Databases and online tools. http://truvenhealth.com/your-healthcare-focus/life-sciences/data-databases-and-online-tools. Accessed 11 Sep 2015
25. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D (2002) Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 27:299–309